Antimicrobial resistance in non-tuberculous mycobacteria in New South Wales, 2002-2008

International Journal of Antimicrobial Agents

Volumn 34, Issue 2, 2009, Pages 182-184

  Foo, H ^a   van Hal, S ^a   Jelfs, P ^a   Gilbert, G L ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; ERYTHROMYCIN; ETHAMBUTOL; IMIPENEM; MACROLIDE; RIFABUTIN; SULFAMETHOXAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DRUG EFFICACY; DRUG TREATMENT FAILURE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MINIMUM LUNG ALVEOLUS CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; NEW SOUTH WALES;

EID: 67349196059     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.01.013     Document Type: Letter

References (7)

1. Wallace R.J., Dalovisio J.R., and Pankey G.A. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother 16 (1979) 611-614
2. Rastogi N., Bauriaud R., Bourgoin A., Carbonnelle B., Chippaux C., Gevaudan M.J., et al. French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex. Antimicrob Agents Chemother 39 (1995) 638-644
3. Yang S.-C., Hsueh P.-R., Lai H.-C., Teng L.J., Huang L.M., Chen J.M., et al. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother 47 (2003) 1958-1962
4. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. ATS mycobacterial diseases subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 (2007) 365-416
5. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard. Document M24-A. Wayne, PA: CLSI; 2003.
6. National Tuberculosis Advisory Committee. Guidelines for Australian Mycobacteriology Laboratories. Communicable diseases intelligence quarterly report 2006; 30:116-28.
7. Heifets L. Susceptibility testing of Mycobacterium avium complex isolates. Antimicrob Agents Chemother 40 (1996) 1759-1767